Cambridge v COVID-19

Cambridge is working hard to ensure that the full strength of the University’s research powers and resources are used in the global fight against COVID-19.

Cambridge v COVID-19

Dear World,
It’s on.
Cambridge v COVID-19.
And it’s a fight we’ll win.
Yours, Cambridge

We’ve been challenged to a fight none of us were expecting, and all over the world, society is being pummelled.

Cambridge is being hit hard too, but we’re fighting back in three arenas:

The Virus
We must find the means to better diagnose, treat and stop the virus causing this pandemic.

Student Support
We must assist our students, whose lives and studies have been upended in so many ways, to stay strong and stay the distance.

The Equipment 
We must ensure high-grade PPE equipment for frontline medical staff and researchers across the UK.

You can help us to knock out COVID-19 and alleviate the bruises it has imparted on our world. A donation of any size to any of the areas below will help advance our work and will have a real and immediate impact.

Together we can defeat COVID-19

Research nurse from the NIHR Clinical Research Facility processing patient samples using SAMBA machines, Addenbrooke’s Hospital
The race is on to find a vaccine against the new COVID-19 coronavirus. Your support will make a difference.
Decorative
Help support students at Cambridge experiencing hardship in this crisis and beyond.
PPE equipment demonstration and ambulance with 4C PPE logo
Our NHS staff are on the frontline and we must guarantee their safety. Help us purchase and transport Personal Protection Equipment from China to Cambridge.

Related impact stories

Philanthropic giving is at the heart of the success of the Collegiate University, enabling us to make discoveries that change the world and to ensure that our students receive an unrivalled education.

Decorative
Philanthropic impact story
The COVID-19 pandemic will have a “profound” impact on philanthropy through forging more active collaboration and ensuring more equitable responses, Bill Gates said in an interview with Badr Jafar (Churchill College, 1997), founding patron of the Centre for Strategic Philanthropy at Cambridge Judge Business School.
decorative
Philanthropic impact story
A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK in late autumn or early next year, thanks to a £1.9million award from the UK government.